NCT03750630 is a clinical trial in Vision Status, sponsored by National Taiwan University Hospital.

Who is sponsoring NCT03750630?

NCT03750630 is sponsored by National Taiwan University Hospital.

What condition does NCT03750630 study?

NCT03750630 studies Vision Status.

Is NCT03750630 still recruiting?

NCT03750630 is currently status unknown. Last updated 23 November 2018.

Last reviewed 2018-11-23 · How we verify

NCT03750630

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Pilot Survey to Establish Vision Health Surveillance Indicators for Children and Adolescent in Taiwan

Status unknown Last updated 23 November 2018

What this trial tests

trial in Vision Status in 10,000 participants. Status unknown.

Timeline

14 April 2016

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	National Taiwan University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	10,000
Start date	14 April 2016
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across Taiwan

Conditions studied

Vision Status — all drugs for Vision Status →

Sponsor

National Taiwan University Hospital

Who can join

Adults 3 to 18, any sex, with Vision Status. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research project is to develop a vision surveillance system, in order of understanding the vision health status of children and adolescents in Taiwan.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Influence of parental behavior on myopigenic behaviors and risk of myopia: analysis of nationwide survey data in children aged 3 to 18 years.
Liu YL, Jhang JP, Hsiao CK, Tsai TH, et al · · 2022 · cited 13× · PMID 36038863 · DOI 10.1186/s12889-022-14036-5
Axial length normative data and percentile curves for schoolchildren in Taiwan: A tool for myopia monitoring.
Liu YL, Lai TT, Wang SW, Tsai TH, et al · · 2025 · cited 2× · PMID 40539728 · DOI 10.1111/opo.13546

Verify or expand the search:

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03750630 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 23 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03750630.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing